Citations as recorded by:

1. Association between clinical features and YMDD mutations in patients with chronic hepatitis B following lamivudine therapy

12(2) p. 847

DOI: 10.3892/etm.2016.3365

Citations as recorded by: Cross Ref PMC Google

2. Intracellular levels of hepatitis B virus DNA and mutational patterns of the polymerase gene of hepatitis B virus in peripheral blood mononuclear cells of patients with lamivudine or telbivudine resistance

9(3) p. 885

DOI: 10.3892/etm.2014.2156

Citations as recorded by: Cross Ref PMC

3. Intracellular levels of hepatitis B virus DNA and mutational patterns of the polymerase gene of hepatitis B virus in peripheral blood mononuclear cells of patients with lamivudine or telbivudine resistance.

Exp Ther Med, 2015, 9 p. 8

Citations as recorded by: Google

4. Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients

WJG, 2015, 21(9) p. 2746

DOI: 10.3748/wjg.v21.i9.2746

Citations as recorded by: Cross Ref PMC Google

5. Prevalence of YMDD Variants Leading to Lamivudine Resistance among Chronic HBV Patients in Gaza Strip-Palestine Running title: Lamivudine Resistance in Gaza …

Year: 2015

Citations as recorded by: Google

6. Anti-hepatitis B activity of isoquinoline alkaloids of plant origin.

Arch. Virol., 2014, 159 p. 1

DOI: 1

Citations as recorded by: Google

7. HBV Genotype B/C and Response to Lamivudine Therapy: A Systematic Review

Biomed Res Int, 2013, 2013

DOI: 10.1155/2013/672614

Citations as recorded by: PMC Google

8. 拉米夫定耐药株感染者基因型, HBVDNA 及多聚酶 P 区基因变异的关系

Year: 2013

Citations as recorded by: Google

9. Prevalence of YMDD Variants Leading to Lamivudine Resistance among Chronic HBV Patients in Gaza Strip-Palestine

Year: 2012

Citations as recorded by: Google

10. Sub-genotyping and Drug Resistance Prediction in Palestinian Hepatitis B Virus (HBV) isolates

Year: 2012

Citations as recorded by: Google